Accessibility Menu
Anteris Technologies Global logo

Anteris Technologies Global(NASDAQ) AVR

Market Cap$802.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+47%
5 YearN/A
1 Year+147%
1 Month-16%
$7.85
-4.73%
-0.39Today
After hours$7.85+$0.00 (+0.00%)
Anteris Technologies Global last closing stock price
MetricPriceDate
Last closeUSD 8.242026-07-30
Anteris Technologies Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.61%USD 8.192026-07-23
1 month-16.35%USD 9.852026-06-30
3 month+29.56%USD 6.362026-05-01
Year to date+65.13%USD 4.992025-12-31
1 year+147.45%USD 3.332025-07-30
Since inception+47.14%USD 5.602024-12-13

Anteris Technologies Global Financials at a Glance

Market Cap

$802.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.85M

Net Income (TTM)

-$95.30M

EPS (TTM)

-$2.22

P/E Ratio

-3.71

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$7.85

Volume

1,034,878.762

Open

$8.27

Previous Close

$7.84

Daily Range

$7.73 - $8.39

52-Week Range

$2.99 - $11.06

Estimated Earnings Date

Aug 14, 2026

AVR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anteris Technologies Global

Anteris makes new heart valves for people with a serious heart condition. These valves help the heart pump blood better through the body. The company's technology aims to make these medical parts last longer.

What Anteris Builds

  • DurAVR Heart Valve: Single-piece valve made to mimic a healthy human heart; uses a unique shape to improve blood flow.
  • ADAPT Tissue: Anti-calcification technology that turns animal tissue into durable bioscaffolds for heart repairs.
  • ComASUR Delivery System: Steerable catheter and balloon system used by doctors to place valves accurately inside the heart.
  • Mitral and Tricuspid Repair: Heart valve repair devices for leaky valves developed through a 30% interest in v2vmedtech.

Strategic Moves and Trials

  • Completed a corporate reorganization and an initial public offering in December 2024.
  • Invested in v2vmedtech in April 2023 to develop devices for treating mitral and tricuspid valve regurgitation.
  • Received Investigational Device Exemption approval from the FDA in November 2025 to start a major clinical study.
  • Enrolled the first patients in the PARADIGM clinical trial in Denmark in October 2025.
  • Entered a manufacturing and services agreement with Switchback Medical in July 2025 for development and testing.

How the Valves Stand Out

Anteris uses a single piece of bioengineered tissue to create heart valves that mimic natural human movement. This design reduces the need for sutures and seams to help prevent wear and calcium buildup over time.

A Look at the Numbers

  • Revenue was $310,000 in Q4 2025, down 42.2% from the previous year.
  • Gross profit reached $219,000 in Q4 2025, down 33.3% from Q4 2024.
  • Net income was -$29.2 million in Q4 2025, a loss that worsened by 50.7% year-over-year.
  • Operating income reached $65.4 million in Q4 2025, improving from a loss in the prior year.
  • Free cash flow hit -$18.8 million in Q4 2025, representing a 0.9% deeper loss compared to the prior year.

The Path Ahead

Anteris has transitioned from a research firm to a development-stage company running global clinical trials. Its focus remains on proving that its biomimetic valve design provides better long-term results for heart patients.

AI Generated • May 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

174

CEO

Wayne Geoffrey Paterson, MBA

Website

www.anteristech.com

Headquarters

Eagan, MN 55121, US

AVR Financials

Key Financial Metrics (TTM)

Gross Margin

28.25%

Operating Margin

-5192.92%

Net Income Margin

-5148.78%

Return on Equity

-124.40%

Return on Capital

-4289.36%

Return on Assets

-32.34%

Earnings Yield

-26.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$802.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

97.34M

Volume

1.03M

Avg. Volume

1.25M

Financials (TTM)

Gross Profit

$523.00K

Operating Income

-$96.12M

EBITDA

-$92.94M

Operating Cash Flow

-$84.99M

Capital Expenditure

-$1.69M

Free Cash Flow

-$86.69M

Cash & ST Invst.

$283.21M

Total Debt

$3.74M

Anteris Technologies Global Performance Analysis

Anteris Technologies Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,200,711N/A
20232023-12-31USD 2,734,821-14.6%
20242024-12-31USD 2,703,000-1.2%
20252025-12-31USD 1,913,000-29.2%
Anteris Technologies Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3011.2%
Q32025-09-30-30.6%
Q42025-12-31-27.7%
Q12026-03-3159.4%
Anteris Technologies Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.85N/A
20232023-12-31USD -1.2850.6%
20242024-12-31USD -2.1265.8%
20252025-12-31USD -2.5520.2%
Anteris Technologies Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-304.3%
Q32025-09-30-5.6%
Q42025-12-31-31.9%
Q12026-03-3125.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$494.00K

-11.2%

Gross Profit

-$49.00K

-114.0%

Gross Margin

-9.92%

N/A

Market Cap

$802.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.61M

N/A

Employees

174

N/A

Net Income

-$23.02M

-5.3%

EBITDA

-$21.95M

-2.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$283.21M

+478.5%

Total Debt

$3.74M

+84.9%

Accounts Receivable

$231.00K

+22.2%

Inventory

$122.00K

-66.5%

Long Term Debt

$2.42M

+329.0%

Short Term Debt

$1.31M

-9.9%

Return on Assets

-32.34%

N/A

Return on Invested Capital

-34.20%

N/A

Free Cash Flow

-$28.82M

-32.6%

Operating Cash Flow

-$28.68M

-33.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANIKAnika Therapeutics, Inc.
$19.28+6.70%
NKTXNkarta, Inc.
$2.09-2.79%
MXCTMaxCyte, Inc.
$1.05+0.00%
OWLTOwlet, Inc.
$5.14-2.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About AVR

What is the current price of Anteris Technologies Global?

Anteris Technologies Global is trading at $7.84 per share.

What is the 52-week range for Anteris Technologies Global?

Over the past 52 weeks, Anteris Technologies Global has traded between $2.99 and $11.06.

How much debt does Anteris Technologies Global have?

As of the most recent reporting period, Anteris Technologies Global reported total debt of $3.74M.

How much cash does Anteris Technologies Global have on hand?

Anteris Technologies Global reported $283.21M in cash and cash equivalents in its most recent financial results.

What is Anteris Technologies Global’s dividend yield?

Anteris Technologies Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services